 |
|
Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor
Da Ru Chi Moon, Dong Kyu Lee, Soon Hyun Kim, Yong Sung You, Oh Woong Kwon
Korean J Ophthalmol. 2015;29(4):226-232. Published online 2015 Jul 21 DOI: https://doi.org/10.3341/kjo.2015.29.4.226
|
|
Citations to this article as recorded by
 Retinal layers changes in patients with age-related macular degeneration treated with intravitreal anti-VEGF agents
Dan Zhou, Yan Hu, Zhongxi Qiu, Zirong Liu, Hongyang Jiang, Ryo Kawasaki, Jiang Liu
BMC Ophthalmology.2023;[Epub] CrossRef Pachychoroid spectrum disease
Shyamanga Borooah, Peng Yong Sim, Sumita Phatak, Gabriella Moraes, Chris Yang Wu, Chui Ming Gemmy Cheung, Bishwanath Pal, Dhiren Bujarborua
Acta Ophthalmologica.2021;[Epub] CrossRef Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
Mohamed A. Hamid, Nizar S. Abdelfattah, Jamshid Salamzadeh, Sahar T. A. Abdelaziz, Ahmed M. Sabry, Khaled M. Mourad, Azza A. Shehab, Baruch D. Kuppermann
International Journal of Retina and Vitreous.2021;[Epub] CrossRef To the Question of Terminology, Expert Criteria for Evaluating the Effectiveness of Antiangiogenic Therapy and the Prevalence of Refractory Forms of Neovascular Age-Related Macular Degeneration. Review
V. G. Likhvantseva, V. N. Trubilin, S. G. Kapkova, A. S. Gevorgyan
Ophthalmology in Russia.2021; 18(3): 389. CrossRef Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response
O.V. Zaytseva, N.V. Neroeva, T.D. Okhotsimskaya, E.V. Bobykin
Vestnik oftal'mologii.2021; 137(5): 152. CrossRef Idiopathic polypoidal choroidal vasculopathy in Caucasians: The POLYON real-life study in 50 naive patients
Hussam El Chehab, Laurent Kodjikian, Constance Lagenaite-Desmaizère, Emilie Agard, Flore De Bats, Thibaud Mathis, Corinne Dot
European Journal of Ophthalmology.2020; 30(5): 948. CrossRef How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview
Theodoros Empeslidis, Matthew Storey, Theodoros Giannopoulos, Vassileios Konidaris, Paris G. Tranos, Evangelia S. Panagiotou, Irini C. Voudouragkaki, Anastasios G. Konstas
Advances in Therapy.2019; 36(7): 1532. CrossRef Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration
In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee
Journal of the Korean Ophthalmological Society.2019; 60(1): 40. CrossRef Up-to-date knowledge on age-related macular degeneration
Kyoung Lae Kim, Sung Pyo Park
Journal of the Korean Medical Association.2018; 61(7): 416. CrossRef Polypoidal choroidal vasculopathy: Pearls in diagnosis and management
Giridhar Anantharaman, Jay Sheth, Muna Bhende, Raja Narayanan, Sundaram Natarajan, Anand Rajendran, George Manayath, Parveen Sen, Rupak Biswas, Alay Banker, Charu Gupta
Indian Journal of Ophthalmology.2018; 66(7): 896. CrossRef Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience
Abdullah Ozkaya, Zeynep Alkin, Mesut Togac, Sibel Ahmet, Irfan Perente, Muhittin Taskapili
Korean Journal of Ophthalmology.2017; 31(5): 424. CrossRef Efficacy of Three Aflibercept Injections for Neovascular Age-related Macular Degeneration Showing Limited Response to Ranibizumab
Kyung Min Kim, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee
Journal of the Korean Ophthalmological Society.2017; 58(1): 62. CrossRef Clinical Experience of Switching Anti-VEGF Therapy from Ranibizumab to Aflibercept in Age-Related Choroidal Neovascularization
Lauren Van Lancker, Robert Petrarca, Kyros Moutsouris, Panos Masaoutis, George Kampougeris
European Journal of Ophthalmology.2017; 27(3): 342. CrossRef Fourteen Anti-vascular Endothelial Growth Factor Injections for Age-related Macular Degeneration: Ending Period and Clinical Outcome
Jae Wook Han, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jung Il Han, Young Ju Lew, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2017; 58(9): 1042. CrossRef One-year Treatment Outcome of Intravitreal Aflibercept for Neovascular Age-related Macular Degeneration with Good Initial Visual Acuity
Jae Hui Kim, Jee Taek Kim, Jong Hyun Oh, Kyung Hoon Shin, Ki Yup Nam
Journal of Retina.2017; 2(1): 21. CrossRef Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration
Nathalie Massamba, Ali Dirani, Nathalie Butel, Christine Fardeau, Bahram Bodaghi, April Ingram, Phuc Lehoang
Graefe's Archive for Clinical and Experimental Ophthalmology.2017; 255(1): 61. CrossRef Polypoidal Choroidal Vasculopathy
Joon-Bom Kim, Rajinder S. Nirwan, Ajay E. Kuriyan
Current Ophthalmology Reports.2017; 5(2): 176. CrossRef Anti-VEGF therapy resistance in neovascular age-related macular degeneration
M. V. Budzinskaya, A. A. Plyukhova, P. A. Sorokin
Vestnik oftal'mologii.2017; 133(4): 103. CrossRef Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Alfredo García-Layana, Marta S. Figueroa, Javier Araiz, José M. Ruiz-Moreno, Francisco Gómez-Ulla, Luis Arias-Barquet, Nicholas Reiter
Drugs & Aging.2015; 32(10): 797. CrossRef
|